CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mecure Industries PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mecure Industries PLC
Me Cure House, Apapa-Oshodi
LAGOS, 102215  Nigeria Ticker: MECUREMECURE
Business Summary
Mecure Industries Plc is a human therapeutics company. The Company is principally in the business of manufacturing drugs, such as tablets, capsules and syrups in Nigeria under two categories namely pharmaceuticals and nutraceuticals. The Company’s Pharmaceuticals segment comprises of over 41 drugs, such as Ebu 200 and 400 (ibuprofen tablets), Laclox, Lamox (an amoxicillin formulation) and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consist of approximately 100 products, including multivitamins and dietary supplements. Its products and services include acute ailment medication, chronic ailment medication, nutraceuticals, multivitamins and a planned expansion into chemotherapy medication. It also offers mobile applications, such as the Smart Pill and Smart Buy applications. These applications serve as online pharmacies that facilitate easy purchase and delivery of Company’s products to retail customers in urban cities.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023-----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board SamirUdani
Co-Chief Executive Officer (Regulatory Affairs, Manufacturing, Quality Control and Assurance and Hu AnderlineDukor
Co-Chief Executive Officer (Finance and Accounts, Logistics, Procurement and Stores) and Director ArjunUdani
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 137 (As of 12/31/2022)
Outstanding Shares: 2,000,000,000 (As of 12/31/2023)
Stock Exchange: NIG
Email Address: info@mecure.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024